84 related articles for article (PubMed ID: 28609708)
1. Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.
Pirat C; Dacquet C; Leclerc V; Hennuyer N; Beucher-Gaudin M; Zanirato G; Géant A; Staels B; Ktorza A; Farce A; Caignard DH; Berthelot P; Lebegue N
Eur J Med Chem; 2017 Sep; 137():310-326. PubMed ID: 28609708
[TBL] [Abstract][Full Text] [Related]
2. Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists.
Hurtevent A; Le Naour M; Leclerc V; Carato P; Melnyk P; Hennuyer N; Staels B; Beucher-Gaudin M; Caignard DH; Dacquet C; Lebegue N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):524-538. PubMed ID: 31939313
[TBL] [Abstract][Full Text] [Related]
3. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.
Artunc F; Sandulache D; Nasir O; Boini KM; Friedrich B; Beier N; Dicks E; Pötzsch S; Klingel K; Amann K; Blazer-Yost BL; Scholz W; Risler T; Kuhl D; Lang F
Pflugers Arch; 2008 May; 456(2):425-36. PubMed ID: 18172605
[TBL] [Abstract][Full Text] [Related]
4. L312, a novel PPARγ ligand with potent anti-diabetic activity by selective regulation.
Xie X; Zhou X; Chen W; Long L; Li W; Yang X; Li S; Wang L
Biochim Biophys Acta; 2015 Jan; 1850(1):62-72. PubMed ID: 25305559
[TBL] [Abstract][Full Text] [Related]
5. Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.
Liu W; Lau F; Liu K; Wood HB; Zhou G; Chen Y; Li Y; Akiyama TE; Castriota G; Einstein M; Wang C; McCann ME; Doebber TW; Wu M; Chang CH; McNamara L; McKeever B; Mosley RT; Berger JP; Meinke PT
J Med Chem; 2011 Dec; 54(24):8541-54. PubMed ID: 22070604
[TBL] [Abstract][Full Text] [Related]
6. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
7. Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
Erbe DV; Gartrell K; Zhang YL; Suri V; Kirincich SJ; Will S; Perreault M; Wang S; Tobin JF
Vascul Pharmacol; 2006 Sep; 45(3):154-62. PubMed ID: 16765099
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel selective PPARγ ligand with partial agonist binding properties by integrated in silico/in vitro work flow.
Kouskoumvekaki I; Petersen RK; Fratev F; Taboureau O; Nielsen TE; Oprea TI; Sonne SB; Flindt EN; Jónsdóttir SÓ; Kristiansen K
J Chem Inf Model; 2013 Apr; 53(4):923-37. PubMed ID: 23432662
[TBL] [Abstract][Full Text] [Related]
9. Novel transcriptome profiling analyses demonstrate that selective peroxisome proliferator-activated receptor γ (PPARγ) modulators display attenuated and selective gene regulatory activity in comparison with PPARγ full agonists.
Tan Y; Muise ES; Dai H; Raubertas R; Wong KK; Thompson GM; Wood HB; Meinke PT; Lum PY; Thompson JR; Berger JP
Mol Pharmacol; 2012 Jul; 82(1):68-79. PubMed ID: 22496518
[TBL] [Abstract][Full Text] [Related]
10. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and activity evaluation of GK/PPARγ dual-target-directed ligands as hypoglycemic agents.
Lu J; Lei L; Huan Y; Li Y; Zhang L; Shen Z; Hu W; Feng Z
ChemMedChem; 2014 May; 9(5):922-7. PubMed ID: 24737574
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect.
Navarrete-Vázquez G; Torres-Gómez H; Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Medina-Franco JL; León-Rivera I; Alarcón-Aguilar FJ; Almanza-Pérez JC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4575-4579. PubMed ID: 25131539
[TBL] [Abstract][Full Text] [Related]
14. Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice.
Ma L; Dong W; Wang R; Li Y; Xu B; Zhang J; Zhao Z; Wang Y
Brain Res Bull; 2015 Jul; 116():67-72. PubMed ID: 26135885
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids.
Colín-Lozano B; Estrada-Soto S; Chávez-Silva F; Gutiérrez-Hernández A; Cerón-Romero L; Giacoman-Martínez A; Almanza-Pérez JC; Hernández-Núñez E; Wang Z; Xie X; Cappiello M; Balestri F; Mura U; Navarrete-Vazquez G
Molecules; 2018 Feb; 23(2):. PubMed ID: 29415496
[TBL] [Abstract][Full Text] [Related]
16. Design, development and evaluation of novel dual PPARδ/PPARγ agonists.
Gathiaka S; Nanayakkara G; Boncher T; Acevedo O; Wyble J; Patel S; Patel A; Shane ME; Bonkowski B; Wieczorek J; Rong Y; Huggins K; Smith F; Amin RH
Bioorg Med Chem Lett; 2013 Feb; 23(3):873-9. PubMed ID: 23273519
[TBL] [Abstract][Full Text] [Related]
17. Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition.
Catalogna G; Moraca F; D'Antona L; Dattilo V; Perrotti G; Lupia A; Costa G; Ortuso F; Iuliano R; Trapasso F; Amato R; Alcaro S; Perrotti N
Eur J Med Chem; 2019 Dec; 183():111675. PubMed ID: 31539779
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
Liu K; Xu L; Berger JP; Macnaul KL; Zhou G; Doebber TW; Forrest MJ; Moller DE; Jones AB
J Med Chem; 2005 Apr; 48(7):2262-5. PubMed ID: 15801817
[TBL] [Abstract][Full Text] [Related]
19. The Role of Sirt1 in Bile Acid Regulation during Calorie Restriction in Mice.
Fu ZD; Cui JY; Klaassen CD
PLoS One; 2015; 10(9):e0138307. PubMed ID: 26372644
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
